Advertisement
Alere Inc. (NYSE: ALR) has recalled 803,000 heart tests following a U.S.Food and Drug Administration inspection of its San Diego plant raised concerns over quality control processes. The company’s stock was down more than 3 percent in morning trading Wednesday, after the announcement.
The tests in question brought in revenue of $69 million in the first quarter.
Advertisement
